Categories: News

PFS Development � Challenges and Solutions, Pre-Filled Syringes East Coast is the Place to Debate

London, United Kingdom, February 03, 2019 –(PR.com)– Despite lucrative opportunities in the PFS industry, there are a few ongoing challenges that the key-leaders battle to overcome, including human factor considerations, new laws, user interface considerations and patient safety. SMi�s Pre-Filled Syringes East Coast Conference (8 – 9 April, Boston, US) is a place to debate these issues, engage with experts and determine strategy.

One of the main features of the event will be what the future of Pre-Filled Syringes and what the drivers will be.

Key sessions include:

Design device strategy for successful implementation of connected devices
– Case study of i-smart, a smart blister tracking device
– Connectivity and data strategy for choosing the right programs
– Setting up the all-important device development programs
– Process of reorganizing funding and financing for device development platforms
Cedric Gysel, Health Care Solutions Design Manager, Johnson & Johnson Design

Early stage device development and understanding cyber security
– De-risk evaluation in terms of early stage device development
– Digital estimations in terms of challenges for patience use and product integrity
– Case study evidence to advise against rushing digital tools to the market and how to ensure they are robust enough
– Advice on cyber security with new devices and the challenges within field
Michael Song, Sr. Manager, Drug Delivery and Device Development, MedImmune

Interactive workshops on April 10th will provide insights into:

· Glass and Polymer – Two Established Materials for Primary Containers – Identify the Best Option
Lead by: Gerressheimer

· Preparing for a Pre-Submission Meeting
Lead by: PAREXEL

More debates, key-note presentations and case-studies are awaiting participants of the Pre-Filled Syringes East Coast Conference – view complete agenda at http://www.pfsamericas.com

Book by February 28th to SAVE $100

Sponsored by:
Aptar Pharma | CSS (CONNECTICUT SPRING & STAMPING) | Harro Höfliger | LONSTROFF | MITSUBISHI GAS CHEMICAL | Owen Mumford | Polyplastics | SCHOTT | Steri-Tek | SUMITOMO RUBBER INDUSTRIES | 3P Innovation | West Pharmaceutical Services | ZEON | ZwickRoell

Limited exhibition opportunities at this sell-out event, get in touch with Alia Malick on +44 (0)20 7827 6156 to discuss how to raise your profile in the most efficient and dynamic way

Twitter – follow #smipfsusa

Pre-Filled Syringes East Coast Conference | April 8 – 9, 2019 | Boston, USA

Let’s block ads! (Why?)

Miscw.com

Recent Posts

Zhengzhou: Interactive Exhibitions on the International Museum Day

ZHENGZHOU, China--(BUSINESS WIRE)--In central China’s Zhengzhou city, visiting museums has become a new trend of…

6 hours ago

Reality TV Star, Mollie Pearce, Backs Campaign to Tackle Inequalities in Condition That Impacts Millions of People Globally

Mollie Pearce, star of the UK reality TV show ‘The Traitors’ who was diagnosed with…

16 hours ago

Quality Building Award 2024 Unveils Finalist List

QBA 2024 Announces 35 Finalists Competing for Hong Kong's Highest Honour in the Building Industry…

2 days ago

UXLINK Tops RootData’s Latest X Hot Items List and DappRadar Social Apps List

SINGAPORE - Media OutReach Newswire - 17 May 2024 - UXLINK, the Web3 social platform…

2 days ago

Australia Construction Industry Report 2024: Growth to Slow to 2% in Real-terms this Year Following 9% Growth in 2023 – Forecasts to 2028 – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Australia Construction Market Size, Trend Analysis by Sector, Competitive Landscape and Forecast to…

2 days ago

Connecting the Dots of ANKTIVA’s Triangle Offense: A Deep Dive with Dr. Patrick Soon-Shiong and Dr. Ashish Kamat in a Three-Part UroToday Podcast

Three-part podcast interview features The mechanism of action of ANKTIVA® activating NK cells, Killer T…

2 days ago